[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website
Drugs at FDA: FDA Approved Drug Products. Links to Initial Search Page FAQ  |  Instructions  |  Glossary  |  Contact Us  |  CDER Home 
Start Over (Drugs@FDA Home)

Drug Details
Drug Name(s) LITHIUM CARBONATE (Generic Drug)
FDA Application No. (ANDA) 079159
Active Ingredient(s) LITHIUM CARBONATE
Company ALEMBIC LTD
Original Approval or Tentative Approval Date January 12, 2009

  • Labels are not available

Products on Application (ANDA) #079159
    Click on a column header to re-sort the table:

Drug Name
Active Ingredients
Strength
Dosage Form/Route
Marketing
Status
RLD
TE
Code
LITHIUM CARBONATE  LITHIUM CARBONATE  150MG  CAPSULE; ORAL  Prescription  No AB  
LITHIUM CARBONATE  LITHIUM CARBONATE  300MG  CAPSULE; ORAL  Prescription  No AB  
LITHIUM CARBONATE  LITHIUM CARBONATE  600MG  CAPSULE; ORAL  Prescription  No AB  

Back to Top | Back to Previous Page | Back to Drugs@FDA Home

Disclaimer
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research
Office of Training and Communications
Division of Information Services
Update Frequency: Daily